Bisphosphonate-related osteonecrosis of the jaw has been a topic of much discussion in dentistry, but the altered bone metabolism as a result of taking this medication and its effect on orthodontic ...

Background: Both raloxifene and bisphosphonates are indicated for the prevention and treatment of postmenopausal osteoporosis, however these medications have different efficacy and safety profiles. It ...

Please provide your email address to receive an email when new articles are posted on . In an update to its guidance on primary osteoporosis, ACP recommended bisphosphonates as a first line of defense ...

The American College of Physicians (ACP) has issued an update of its guideline with clinical recommendations for treatments of primary osteoporosis and low bone mass in adults. In the new guideline, ...

Please provide your email address to receive an email when new articles are posted on . “Although we observed an increasing number of osteonecrosis of the jaw cases in our daily practice during the ...

Measures of bone health can be used to identify a subset of patients with osteoporosis who have a high risk for fracture if they take a break from bisphosphonate therapy. "These results highlight the ...

1. American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary ...

The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults. In a shift from previous recommendations, the ...